Highlights • China can realise the HBV elimination targets regarding incidence by 2025 but not in HBV-related mortality until 2059. • Upscaling the diagnostic, linkage-to-care, and treatment coverages would save 2 million lives from HBV-related deaths. • Potent novel therapies would further save 1.5–2 million lives and reach the HBV mortality target 10–20 years earlier.
All Keywords
【저자키워드】 HBV, cirrhosis, Viral hepatitis, WHO, HCC,
【저자키워드】 HBV, cirrhosis, Viral hepatitis, WHO, HCC,